Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
A meta-analysis update of randomized controlled trials investigating recombinant human erythropoietin suggests improved neurodevelopmental outcome in preterm infants. There was substantial heterogeneity, which could be ascribed to a single trial. Exclusion of this trial featuring a high risk of bias...
Saved in:
Main Authors: | Hendrik S. Fischer (Author), Nora J. Reibel (Author), Christoph Bührer (Author), Christof Dame (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aberrant Hematopoiesis and Morbidity in Extremely Preterm Infants With Intrauterine Growth Restriction
by: Nora J. Reibel, et al.
Published: (2021) -
Immature Platelet Counts and Thrombopoietin Plasma Concentrations in Thrombocytopenic and Non-thrombocytopenic Preterm Infants
by: Hannes Sallmon, et al.
Published: (2021) -
Early administration of erythropoietin in extremely very low birth weight preterms
by: Mihaela Demetrian, et al.
Published: (2019) -
Prophylactic Use of Fluconazole in Very Premature Infants
by: Deshuang Zhang, et al.
Published: (2021) -
Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis
by: Abdulrahman Al-matary, et al.
Published: (2022)